ABN AMRO Bank N.V. (0RDM)
London Exchange · UK · prices in EUR · close of 15 Oct 2026
Key indicators
| Last close | EUR 40.38 |
|---|---|
| 52-week range | 23.76 – 44.77 |
| Return, 1 month / 3 months | −6.1% / +6.8% |
| Return, 1 year / 3 years | +65.9% / +271.2% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 40 |
| Volatility (1 year) | 27.8% |
| Worst drawdown (1 year) | -21.1% |
| Average daily value traded | 49.35M EUR |
| Dividend yield | 4.2% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
ABN AMRO Bank is a Dutch financial institution based in Amsterdam that serves retail, private and business customers. It offers mortgages, savings accounts, loans, payment services and everyday banking to individuals and households, while its business banking arm supports small and medium-sized enterprises. The bank also provides corporate and investment banking services, including lending, trade finance and advisory work, to larger companies and institutional clients, and it manages wealth for private clients.
ABN AMRO Bank N.V. trades under the code 0RDM on the London Exchange in UK, with its price quoted in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
ABN AMRO Bank N.V. (0RDM) trades on the London Exchange in UK. It last closed at EUR 40.38 on 15 October 2026.
Its price-based Market X-Ray is 78 out of 100 (a strong price profile), ranking 110 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 65.9% and over the last three months it rose 6.8%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 86 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 19.8% | ||
| From 52-week high | -8.3% | ||
| Momentum | 86 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 6.8% | ||
| 6-month return | 40.4% | ||
| 12-month return, skipping the last month | 76.7% | ||
| Stability (higher is calmer) | 69 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 27.8% | ||
| Worst drawdown, 1 year (smaller is calmer) | -21.1% | ||
| Liquidity | 84 · Strong | Trades actively. | |
| Average daily value traded | 49.35M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 54 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 4.2% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Liquidity: Trades actively.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | +1.2% |
|---|---|
| 1 month | −6.1% |
| 3 months | +6.8% |
| 6 months | +40.4% |
| 1 year | +65.9% |
| 3 years | +271.2% |
| 5 years | +372.7% |
Signals
| 50-day / 200-day average | 41.77 / 33.69 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.01 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 19 Aug 2026 | EUR 0.6800 |
| 24 Apr 2026 | EUR 1.0048 |
| 13 Aug 2025 | EUR 0.5400 |
| 25 Apr 2025 | EUR 0.7500 |
| 14 Aug 2024 | EUR 0.6000 |
| 26 Apr 2024 | EUR 0.8900 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.